Masimo Corporation

The momentum for this stock is not very good. Masimo Corporation is not very popular among insiders. Masimo Corporation is a mediocre stock to choose.
Log in to see more information.
Masimo Corp. is a medical technology company, which develops, manufactures and markets non invasive...

News

Leading Proxy Advisory Firm Egan-Jones Recommends Stockholders Vote FOR Masimos Director Nominees, Joe Kiani and Christopher Chavez
Leading Proxy Advisory Firm Egan-Jones Recommends Stockholders Vote FOR Masimos Director Nominees, Joe Kiani and Christopher Chavez

Business Wire Masimo Corporation (Masimo or the Company) (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today announced that leading proxy advisory firm Egan-Jones has...\n more…

Masimos Lawsuit Forced Politan and Quentin Koffey to Issue Corrective Disclosures on False and Misleading Statements Made to Masimo Stockholders on Issues Material to the Proxy Contest
Masimos Lawsuit Forced Politan and Quentin Koffey to Issue Corrective Disclosures on False and Misleading Statements Made to Masimo Stockholders on Issues Material to the Proxy Contest

Business Wire Masimo Corporation (Masimo or the Company) (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today set the record straight in response to Politan Capital...\n more…

Politan Comments on Judges Decision to Deny Masimos Request for a Preliminary Injunction
Politan Comments on Judges Decision to Deny Masimos Request for a Preliminary Injunction

Business Wire Politan Capital Management (together with its affiliates, Politan), an 8.9% shareholder of Masimo Corporation (Masimo or the Company) (NASDAQ: MASI), issued the following statement regarding last...\n more…

Arizona State Retirement System Buys 247 Shares of Masimo Co. (NASDAQ:MASI)
Arizona State Retirement System Buys 247 Shares of Masimo Co. (NASDAQ:MASI)

Ticker Report Arizona State Retirement System raised its position in shares of Masimo Co. (NASDAQ:MASI - Free Report) by 2.0% in the second quarter, HoldingsChannel reports. The fund owned 12,591 shares of the...\n more…

Apple Watch Upgrade A Downgrade? Top Analyst Says Many Missed This Crucial Information During 'Glowtime' Event
Apple Watch Upgrade A Downgrade? Top Analyst Says Many Missed This Crucial Information During 'Glowtime' Event

Benzinga Mark Gurman highlighted that the new Apple Watch Series 10 lacks Blood Oxygen monitoring due to an ongoing patent dispute with Masimo, potentially deterring upgrades from users of Series 6 or newer models.\n more…

Masimos Future Depends on Vote at September 19 Annual Meeting
Masimos Future Depends on Vote at September 19 Annual Meeting

Business Wire Masimo Corporation (Masimo or the Company) (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today mailed a letter to stockholders in connection with its...\n more…